2018 临床建议:结节性硬化相关性癫痫的管理

2018-05-24 国外神经内科相关专家小组(统称) Eur J Paediatr Neurol. 2018 May 24.

结节性硬化患者发生癫痫的风险非常高,2012年来自欧洲的专家小组发布了结节性硬化患者癫痫管理临床建议,本文是对该建议的更新。

中文标题:

2018 临床建议:结节性硬化相关性癫痫的管理

英文标题:

Management of epilepsy associated with tuberous sclerosis complex: Updated clinical recommendations.

发布日期:

2018-05-24

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 临床建议:结节性硬化相关性癫痫的管理)] GetToolGuiderByIdResponse(projectId=1, id=3dc8e1c001613089, title=2018 临床建议:结节性硬化相关性癫痫的管理, enTitle=Management of epilepsy associated with tuberous sclerosis complex: Updated clinical recommendations., guiderFrom=Eur J Paediatr Neurol. 2018 May 24., authorId=null, author=, summary=结节性硬化患者发生癫痫的风险非常高,2012年来自欧洲的专家小组发布了结节性硬化患者癫痫管理临床建议,本文是对该建议的更新。 , cover=, journalId=null, articlesId=null, associationId=952, associationName=国外神经内科相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Thu May 24 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>结节性硬化患者发生癫痫的风险非常高,2012年来自欧洲的专家小组发布了结节性硬化患者癫痫管理临床建议,本文是对该建议的更新。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>癫痫</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=48e001c0016080f7" title="2018 AAN/AES实践指南:新型抗癫痫药的疗效和耐受性——第二部分:治性癫痫的治疗" target=_blank>2018 AAN/AES实践指南:新型抗癫痫药的疗效和耐受性——第二部分:治性癫痫的治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=b0f441c00160e9a7" title="2018 AAN/AES实践指南:新型抗癫痫药的疗效和耐受性——第一部分:新发癫痫的治疗" target=_blank>2018 AAN/AES实践指南:新型抗癫痫药的疗效和耐受性——第一部分:新发癫痫的治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=ac7831c00160e093" title="2018 ILAE循证建议:成人和儿童癫痫患者的心理治疗" target=_blank>2018 ILAE循证建议:成人和儿童癫痫患者的心理治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=65f241c001602884" title="2018 国际生酮饮食研究组建议:优化接受饮食疗法治疗癫痫的儿童患者的临床管理" target=_blank>2018 国际生酮饮食研究组建议:优化接受饮食疗法治疗癫痫的儿童患者的临床管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=d83011c0015ae384" title="中医儿科临床诊疗指南·小儿癫痫( 修订)" target=_blank>中医儿科临床诊疗指南·小儿癫痫( 修订)</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E7%99%AB%E7%97%AB" target=_blank>有关癫痫更多指南</a></ul>, tagList=[TagDto(tagId=77530, tagName=结节性硬化相关性癫痫)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3955, appHits=143, showAppHits=0, pcHits=3060, showPcHits=1152, likes=146, shares=5, comments=3, approvalStatus=1, publishedTime=Sun Jul 08 23:09:56 CST 2018, publishedTimeString=2018-05-24, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Jul 08 23:09:56 CST 2018, updatedBy=null, updatedName=null, updatedTime=Wed Jan 03 02:07:24 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 临床建议:结节性硬化相关性癫痫的管理)])
2018 临床建议:结节性硬化相关性癫痫的管理
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=380936, encodeId=606f380936c2, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/18/eecc233db400358394ffb9af0e981132.jpg, createdBy=c9ba5080517, createdName=努力克服拖延症, createdTime=Wed Mar 25 00:00:51 CST 2020, time=2020-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=330477, encodeId=479c3304e7ee, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Mon Jul 09 23:46:01 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=330284, encodeId=022f3302843d, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Jul 09 00:21:41 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=330257, encodeId=ec1333025ee9, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Sun Jul 08 23:28:20 CST 2018, time=2018-07-08, status=1, ipAttribution=)]
    2020-03-25 努力克服拖延症

    感谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=380936, encodeId=606f380936c2, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/18/eecc233db400358394ffb9af0e981132.jpg, createdBy=c9ba5080517, createdName=努力克服拖延症, createdTime=Wed Mar 25 00:00:51 CST 2020, time=2020-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=330477, encodeId=479c3304e7ee, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Mon Jul 09 23:46:01 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=330284, encodeId=022f3302843d, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Jul 09 00:21:41 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=330257, encodeId=ec1333025ee9, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Sun Jul 08 23:28:20 CST 2018, time=2018-07-08, status=1, ipAttribution=)]
    2018-07-09 清风拂面

    谢谢分享学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=380936, encodeId=606f380936c2, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/18/eecc233db400358394ffb9af0e981132.jpg, createdBy=c9ba5080517, createdName=努力克服拖延症, createdTime=Wed Mar 25 00:00:51 CST 2020, time=2020-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=330477, encodeId=479c3304e7ee, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Mon Jul 09 23:46:01 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=330284, encodeId=022f3302843d, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Jul 09 00:21:41 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=330257, encodeId=ec1333025ee9, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Sun Jul 08 23:28:20 CST 2018, time=2018-07-08, status=1, ipAttribution=)]
    2018-07-09 1209e435m98(暂无昵称)

    学习了.谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=380936, encodeId=606f380936c2, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/18/eecc233db400358394ffb9af0e981132.jpg, createdBy=c9ba5080517, createdName=努力克服拖延症, createdTime=Wed Mar 25 00:00:51 CST 2020, time=2020-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=330477, encodeId=479c3304e7ee, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Mon Jul 09 23:46:01 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=330284, encodeId=022f3302843d, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Mon Jul 09 00:21:41 CST 2018, time=2018-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=330257, encodeId=ec1333025ee9, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Sun Jul 08 23:28:20 CST 2018, time=2018-07-08, status=1, ipAttribution=)]
    2018-07-08 清风拂面

    谢谢分享学习

    0